CREB1 and acute myeloid leukemia: Quantitative RT-PCR data showed that niclosamide significantly decreased mRNA expression levels of RFC3 and POLD2 in HL60 cells (Figure 5B), suggesting that niclosamide downregulates CREB-target genes to induce apoptosis and cell cycle arrest in AML cells.